The Valley Fever Institute at Kern Medical Officially Announces Launch of New Valley Fever Research Study
- Posted On:
- Written By: Kern Medical
The Valley Fever Institute at Kern Medical has launched a new Valley Fever research study in partnership with Duke University. This study will provide The National Institute of Health with data on the prevalence of Valley Fever in local residents who have been diagnosed with Community Acquired Pneumonia (CAP).
The Valley Fever Institute at Kern Medical announced the launch of this study at a press conference held at Kern Medical on January 28, 2019. The event included a Q&A with Dr. Royce Johnson, Medical Director of the Valley Fever Institute at Kern Medical and Chief of Infectious Disease at Kern Medical.
The Valley Fever research study is open to patients 14 years of age or older, who have been diagnosed with CAP in the last 14 days or have been diagnosed with both CAP and Valley Fever in the last 14 days. Study eligibility depends on study enrollment within 14 days of a CAP or CAP/Valley Fever diagnosis. Qualifying participants will receive up to $600 to assist with the cost of travel and time. All study care, visits and blood draws are at no cost to the participant.
If you would like to refer a patient to the study or speak to a study team member, please call 661.706.6748.